4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-25-018206
Options or other derivatives
- Chief Corp Development Officer acquired 150,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Cote Elissa S. Chief Corp Development Officer | 2025-06-23 | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | D | ||
Loading xslF345X05/form4-06252025_090633.xml…